Search by Drug Name or NDC

    NDC 50090-3482-00 FARXIGA 5 mg/1 Details

    FARXIGA 5 mg/1

    FARXIGA is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by A-S Medication Solutions. The primary component is DAPAGLIFLOZIN PROPANEDIOL.

    Product Information

    NDC 50090-3482
    Product ID 50090-3482_de360b4e-6a91-4439-9f4d-475de2d8f08b
    Associated GPIs 27700040200310
    GCN Sequence Number 071740
    GCN Sequence Number Description dapagliflozin propanediol TABLET 5 MG ORAL
    HIC3 C4D
    HIC3 Description ANTIHYPERGLYCEMIC-SOD/GLUC COTRANSPORT2(SGLT2) INH
    GCN 35698
    HICL Sequence Number 040137
    HICL Sequence Number Description DAPAGLIFLOZIN PROPANEDIOL
    Brand/Generic Generic
    Proprietary Name FARXIGA
    Proprietary Name Suffix n/a
    Non-Proprietary Name DAPAGLIFLOZIN
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED
    Route ORAL
    Active Ingredient Strength 5
    Active Ingredient Units mg/1
    Substance Name DAPAGLIFLOZIN PROPANEDIOL
    Labeler Name A-S Medication Solutions
    Pharmaceutical Class Sodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA202293
    Listing Certified Through 2024-12-31

    Package

    NDC 50090-3482-00 (50090348200)

    NDC Package Code 50090-3482-0
    Billing NDC 50090348200
    Package 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50090-3482-0)
    Marketing Start Date 2018-06-15
    NDC Exclude Flag N
    Pricing Information N/A